- (18R)-12-methoxyibogamine
- 12 Methoxyibogamine', "6,9-Methano-5H-pyrido(1',2':1,2)azepino(4,5-b)indole, ibogamine deriv.", "6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole, ibogamine deriv.", '(1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo(13.3.1.02,10.04,9.013,18)nonadeca-2(10),4(9),5,7-tetraene
- (-)-Ibogaine
- IBOGAINE [VANDF]
- CHEMBL1215855
- HSDB 8180
- (1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene
- DTXCID401324112
- Ibogamine, 12-methoxy-
- DEA No. 7260
- FS-9083
- IBOGAINE
- IBOGAINE (MART.)', "7-Ethyl-6,6beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido(1',2':1,2)azepino(5,4-b)indole", 'Tabernanthe iboga
- SCHEMBL113571
- EINECS 201-498-4
- 83-74-9
- DTXSID20894069
- (1R,15S,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene
- BDBM50308247
- Ibogain
- Q409455
- Endabuse
- UNII-3S814I130U
- NSC 249764
- NS00041096
- CHEBI:5852
- HJM
- IBOGAINE [MI]
- HSIBGVUMFOSJPD-CFDPKNGZSA-N
- Ibogaine (8CI)
- IBOGAINE [MART.]
- IBOGAINE [WHO-DD]
- (1R,15S,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo(13.3.1.02,10.04,9.013,18)nonadeca-2(10),4(9),5,7-tetraene
- NIH 10567
- (5beta)-12-methoxyibogamine
- 3S814I130U
- NSC-249764
- GTPL13148
- 12-Methoxyibogamine
- Ibogaine
|